G Medical Innovations Holdings Ltd (NASDAQ: GMVD) Stock Competitors & Peer Comparison
See GMVD's competitors and their performance on the NASDAQ and across the wider stock market.
Peer Comparison Table: Medical - Instruments & Supplies Industry
Detailed financial metrics including price, market cap, P/E ratio, and more for GMVD and its NASDAQ peers.
| Symbol | Price | Change % | Market Cap | P/E Ratio | EPS | Dividend Yield |
|---|---|---|---|---|---|---|
| GMVD | $0.18 | +1.38% | 1.8M | -0.01 | -$18.76 | N/A |
| BDX | $156.36 | +2.22% | 56.6B | 11.62 | $13.45 | +2.39% |
| BDXA | $59.24 | -2.24% | 55.9B | 45.70 | $1.30 | +2.39% |
| MDLN | $38.75 | +2.98% | 32.8B | 45.06 | $0.86 | N/A |
| WST | $328.20 | -7.67% | 23.2B | 41.19 | $7.97 | +0.26% |
| HOLX | $76.01 | +0.00% | 17B | 31.54 | $2.41 | N/A |
| COO | $70.31 | +0.11% | 13.7B | 15.42 | $4.56 | N/A |
| BDXB | $48.16 | +1.39% | 13.7B | 7.60 | $6.33 | +2.39% |
| BAX | $22.40 | +3.37% | 11.6B | 10.77 | $2.08 | +0.89% |
| ATR | $132.36 | +2.61% | 8.4B | 23.13 | $5.72 | +1.43% |
Stock Comparison
Becton, Dickinson and Company (NYSE: BDX)
GMVD vs BDX Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, BDX has a market cap of 56.6B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while BDX trades at $156.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas BDX's P/E ratio is 11.62. In terms of profitability, GMVD's ROE is +2.09%, compared to BDX's ROE of +0.05%. Regarding short-term risk, GMVD is more volatile compared to BDX. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check BDX's competition here
Becton, Dickinson and Company (NYSE: BDXA)
GMVD vs BDXA Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, BDXA has a market cap of 55.9B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while BDXA trades at $59.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas BDXA's P/E ratio is 45.70. In terms of profitability, GMVD's ROE is +2.09%, compared to BDXA's ROE of +0.05%. Regarding short-term risk, GMVD is more volatile compared to BDXA. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check BDXA's competition here
Medline Inc. (NASDAQ: MDLN)
GMVD vs MDLN Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, MDLN has a market cap of 32.8B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while MDLN trades at $38.75.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas MDLN's P/E ratio is 45.06. In terms of profitability, GMVD's ROE is +2.09%, compared to MDLN's ROE of +0.07%. Regarding short-term risk, GMVD is more volatile compared to MDLN. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check MDLN's competition here
West Pharmaceutical Services, Inc. (NYSE: WST)
GMVD vs WST Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, WST has a market cap of 23.2B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while WST trades at $328.20.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas WST's P/E ratio is 41.19. In terms of profitability, GMVD's ROE is +2.09%, compared to WST's ROE of +0.19%. Regarding short-term risk, GMVD is more volatile compared to WST. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check WST's competition here
Hologic, Inc. (NASDAQ: HOLX)
GMVD vs HOLX Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, HOLX has a market cap of 17B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while HOLX trades at $76.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas HOLX's P/E ratio is 31.54. In terms of profitability, GMVD's ROE is +2.09%, compared to HOLX's ROE of +0.11%. Regarding short-term risk, GMVD is more volatile compared to HOLX. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check HOLX's competition here
The Cooper Companies, Inc. (NASDAQ: COO)
GMVD vs COO Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, COO has a market cap of 13.7B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while COO trades at $70.31.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas COO's P/E ratio is 15.42. In terms of profitability, GMVD's ROE is +2.09%, compared to COO's ROE of +0.03%. Regarding short-term risk, GMVD is more volatile compared to COO. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check COO's competition here
Becton, Dickinson and Company (NYSE: BDXB)
GMVD vs BDXB Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, BDXB has a market cap of 13.7B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while BDXB trades at $48.16.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas BDXB's P/E ratio is 7.60. In terms of profitability, GMVD's ROE is +2.09%, compared to BDXB's ROE of +0.05%. Regarding short-term risk, GMVD is more volatile compared to BDXB. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check BDXB's competition here
Baxter International Inc. (NYSE: BAX)
GMVD vs BAX Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, BAX has a market cap of 11.6B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while BAX trades at $22.40.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas BAX's P/E ratio is 10.77. In terms of profitability, GMVD's ROE is +2.09%, compared to BAX's ROE of -0.16%. Regarding short-term risk, GMVD is more volatile compared to BAX. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check BAX's competition here
AptarGroup, Inc. (NYSE: ATR)
GMVD vs ATR Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ATR has a market cap of 8.4B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ATR trades at $132.36.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ATR's P/E ratio is 23.13. In terms of profitability, GMVD's ROE is +2.09%, compared to ATR's ROE of +0.14%. Regarding short-term risk, GMVD is more volatile compared to ATR. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ATR's competition here
Avantor, Inc. (NYSE: AVTR)
GMVD vs AVTR Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, AVTR has a market cap of 7.8B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while AVTR trades at $11.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas AVTR's P/E ratio is 13.46. In terms of profitability, GMVD's ROE is +2.09%, compared to AVTR's ROE of -0.10%. Regarding short-term risk, GMVD is more volatile compared to AVTR. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check AVTR's competition here
Repligen Corporation (NASDAQ: RGEN)
GMVD vs RGEN Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, RGEN has a market cap of 7.4B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while RGEN trades at $131.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas RGEN's P/E ratio is 73.31. In terms of profitability, GMVD's ROE is +2.09%, compared to RGEN's ROE of +0.02%. Regarding short-term risk, GMVD is more volatile compared to RGEN. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check RGEN's competition here
Teleflex Incorporated (NYSE: TFX)
GMVD vs TFX Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, TFX has a market cap of 5.8B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while TFX trades at $132.10.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas TFX's P/E ratio is 12.32. In terms of profitability, GMVD's ROE is +2.09%, compared to TFX's ROE of -0.28%. Regarding short-term risk, GMVD is more volatile compared to TFX. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check TFX's competition here
Bausch + Lomb Corporation (NYSE: BLCO)
GMVD vs BLCO Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, BLCO has a market cap of 5.8B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while BLCO trades at $16.17.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas BLCO's P/E ratio is 24.88. In terms of profitability, GMVD's ROE is +2.09%, compared to BLCO's ROE of -0.03%. Regarding short-term risk, GMVD is more volatile compared to BLCO. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check BLCO's competition here
Stevanato Group S.p.A. (NYSE: STVN)
GMVD vs STVN Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, STVN has a market cap of 5.4B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while STVN trades at $19.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas STVN's P/E ratio is 31.81. In terms of profitability, GMVD's ROE is +2.09%, compared to STVN's ROE of +0.10%. Regarding short-term risk, GMVD is more volatile compared to STVN. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check STVN's competition here
Merit Medical Systems, Inc. (NASDAQ: MMSI)
GMVD vs MMSI Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, MMSI has a market cap of 4.4B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while MMSI trades at $74.32.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas MMSI's P/E ratio is 19.01. In terms of profitability, GMVD's ROE is +2.09%, compared to MMSI's ROE of +0.09%. Regarding short-term risk, GMVD is more volatile compared to MMSI. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check MMSI's competition here
ICU Medical, Inc. (NASDAQ: ICUI)
GMVD vs ICUI Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ICUI has a market cap of 3.9B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ICUI trades at $157.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ICUI's P/E ratio is 19.66. In terms of profitability, GMVD's ROE is +2.09%, compared to ICUI's ROE of +0.02%. Regarding short-term risk, GMVD is more volatile compared to ICUI. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ICUI's competition here
Haemonetics Corporation (NYSE: HAE)
GMVD vs HAE Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, HAE has a market cap of 3.6B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while HAE trades at $78.78.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas HAE's P/E ratio is 15.86. In terms of profitability, GMVD's ROE is +2.09%, compared to HAE's ROE of +0.11%. Regarding short-term risk, GMVD is more volatile compared to HAE. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check HAE's competition here
DENTSPLY SIRONA Inc. (NASDAQ: XRAY)
GMVD vs XRAY Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, XRAY has a market cap of 2.6B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while XRAY trades at $12.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas XRAY's P/E ratio is 9.04. In terms of profitability, GMVD's ROE is +2.09%, compared to XRAY's ROE of -0.41%. Regarding short-term risk, GMVD is more volatile compared to XRAY. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check XRAY's competition here
LeMaitre Vascular, Inc. (NASDAQ: LMAT)
GMVD vs LMAT Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, LMAT has a market cap of 2.2B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while LMAT trades at $95.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas LMAT's P/E ratio is 37.05. In terms of profitability, GMVD's ROE is +2.09%, compared to LMAT's ROE of +0.16%. Regarding short-term risk, GMVD is more volatile compared to LMAT. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check LMAT's competition here
Pulse Biosciences, Inc. (NASDAQ: PLSE)
GMVD vs PLSE Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, PLSE has a market cap of 2.1B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while PLSE trades at $30.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas PLSE's P/E ratio is -27.48. In terms of profitability, GMVD's ROE is +2.09%, compared to PLSE's ROE of -0.87%. Regarding short-term risk, GMVD is more volatile compared to PLSE. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check PLSE's competition here
AtriCure, Inc. (NASDAQ: ATRC)
GMVD vs ATRC Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ATRC has a market cap of 1.8B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ATRC trades at $35.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ATRC's P/E ratio is 1088.20. In terms of profitability, GMVD's ROE is +2.09%, compared to ATRC's ROE of +0.02%. Regarding short-term risk, GMVD is more volatile compared to ATRC. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ATRC's competition here
BioLife Solutions, Inc. (NASDAQ: BLFS)
GMVD vs BLFS Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, BLFS has a market cap of 1.5B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while BLFS trades at $29.98.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas BLFS's P/E ratio is -141.85. In terms of profitability, GMVD's ROE is +2.09%, compared to BLFS's ROE of -0.03%. Regarding short-term risk, GMVD is more volatile compared to BLFS. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check BLFS's competition here
Azenta, Inc. (NASDAQ: AZTA)
GMVD vs AZTA Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, AZTA has a market cap of 1.3B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while AZTA trades at $27.37.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas AZTA's P/E ratio is 60.82. In terms of profitability, GMVD's ROE is +2.09%, compared to AZTA's ROE of -0.11%. Regarding short-term risk, GMVD is more volatile compared to AZTA. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check AZTA's competition here
Kestra Medical Technologies, Ltd. (NASDAQ: KMTS)
GMVD vs KMTS Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, KMTS has a market cap of 1.2B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while KMTS trades at $21.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas KMTS's P/E ratio is -8.92. In terms of profitability, GMVD's ROE is +2.09%, compared to KMTS's ROE of -0.59%. Regarding short-term risk, GMVD is more volatile compared to KMTS. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check KMTS's competition here
STAAR Surgical Company (NASDAQ: STAA)
GMVD vs STAA Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, STAA has a market cap of 1.2B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while STAA trades at $23.38.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas STAA's P/E ratio is 41.02. In terms of profitability, GMVD's ROE is +2.09%, compared to STAA's ROE of -0.06%. Regarding short-term risk, GMVD is more volatile compared to STAA. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check STAA's competition here
QuidelOrtho Corporation (NASDAQ: QDEL)
GMVD vs QDEL Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, QDEL has a market cap of 1.1B. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while QDEL trades at $16.05.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas QDEL's P/E ratio is 11.98. In terms of profitability, GMVD's ROE is +2.09%, compared to QDEL's ROE of -0.56%. Regarding short-term risk, GMVD is more volatile compared to QDEL. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check QDEL's competition here
Atrion Corporation (NASDAQ: ATRI)
GMVD vs ATRI Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ATRI has a market cap of 809.4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ATRI trades at $459.92.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ATRI's P/E ratio is 64.50. In terms of profitability, GMVD's ROE is +2.09%, compared to ATRI's ROE of +0.08%. Regarding short-term risk, GMVD is more volatile compared to ATRI. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ATRI's competition here
AngioDynamics, Inc. (NASDAQ: ANGO)
GMVD vs ANGO Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ANGO has a market cap of 561.7M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ANGO trades at $13.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ANGO's P/E ratio is -34.85. In terms of profitability, GMVD's ROE is +2.09%, compared to ANGO's ROE of -0.21%. Regarding short-term risk, GMVD is more volatile compared to ANGO. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ANGO's competition here
Anbio Biotechnology Class A Ordinary Shares (NASDAQ: NNNN)
GMVD vs NNNN Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, NNNN has a market cap of 441.5M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while NNNN trades at $9.90.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas NNNN's P/E ratio is 145.38. In terms of profitability, GMVD's ROE is +2.09%, compared to NNNN's ROE of +0.27%. Regarding short-term risk, GMVD is more volatile compared to NNNN. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check NNNN's competition here
OraSure Technologies, Inc. (NASDAQ: OSUR)
GMVD vs OSUR Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, OSUR has a market cap of 273.3M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while OSUR trades at $3.97.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas OSUR's P/E ratio is -4.78. In terms of profitability, GMVD's ROE is +2.09%, compared to OSUR's ROE of -0.21%. Regarding short-term risk, GMVD is more volatile compared to OSUR. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check OSUR's competition here
Sanara MedTech Inc. (NASDAQ: SMTI)
GMVD vs SMTI Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, SMTI has a market cap of 234.2M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while SMTI trades at $25.56.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas SMTI's P/E ratio is -426.00. In terms of profitability, GMVD's ROE is +2.09%, compared to SMTI's ROE of -2.46%. Regarding short-term risk, GMVD is more volatile compared to SMTI. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check SMTI's competition here
Utah Medical Products, Inc. (NASDAQ: UTMD)
GMVD vs UTMD Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, UTMD has a market cap of 213.8M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while UTMD trades at $67.14.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas UTMD's P/E ratio is 19.86. In terms of profitability, GMVD's ROE is +2.09%, compared to UTMD's ROE of +0.09%. Regarding short-term risk, GMVD is more volatile compared to UTMD. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check UTMD's competition here
InfuSystem Holdings, Inc. (AMEX: INFU)
GMVD vs INFU Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, INFU has a market cap of 183.9M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while INFU trades at $9.12.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas INFU's P/E ratio is 23.97. In terms of profitability, GMVD's ROE is +2.09%, compared to INFU's ROE of +0.14%. Regarding short-term risk, GMVD is more volatile compared to INFU. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check INFU's competition here
KORU Medical Systems, Inc. (NASDAQ: KRMD)
GMVD vs KRMD Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, KRMD has a market cap of 175.9M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while KRMD trades at $3.83.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas KRMD's P/E ratio is -95.75. In terms of profitability, GMVD's ROE is +2.09%, compared to KRMD's ROE of -0.14%. Regarding short-term risk, GMVD is more volatile compared to KRMD. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check KRMD's competition here
Pro-Dex, Inc. (NASDAQ: PDEX)
GMVD vs PDEX Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, PDEX has a market cap of 175.4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while PDEX trades at $54.93.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas PDEX's P/E ratio is 19.34. In terms of profitability, GMVD's ROE is +2.09%, compared to PDEX's ROE of +0.29%. Regarding short-term risk, GMVD is more volatile compared to PDEX. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check PDEX's competition here
Microbot Medical Inc. (NASDAQ: MBOT)
GMVD vs MBOT Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, MBOT has a market cap of 77.9M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while MBOT trades at $1.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas MBOT's P/E ratio is -6.58. In terms of profitability, GMVD's ROE is +2.09%, compared to MBOT's ROE of -0.22%. Regarding short-term risk, GMVD is more volatile compared to MBOT. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check MBOT's competition here
Akoya Biosciences, Inc. (NASDAQ: AKYA)
GMVD vs AKYA Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, AKYA has a market cap of 64.4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while AKYA trades at $1.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas AKYA's P/E ratio is -1.34. In terms of profitability, GMVD's ROE is +2.09%, compared to AKYA's ROE of -1.80%. Regarding short-term risk, GMVD is more volatile compared to AKYA. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check AKYA's competition here
SkyAI, Inc. (NASDAQ: STSS)
GMVD vs STSS Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, STSS has a market cap of 58.4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while STSS trades at $1.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas STSS's P/E ratio is -0.02. In terms of profitability, GMVD's ROE is +2.09%, compared to STSS's ROE of -1.66%. Regarding short-term risk, GMVD is more volatile compared to STSS. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check STSS's competition here
Daxor Corporation (NASDAQ: DXR)
GMVD vs DXR Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, DXR has a market cap of 52.7M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while DXR trades at $10.45.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas DXR's P/E ratio is 27.33. In terms of profitability, GMVD's ROE is +2.09%, compared to DXR's ROE of +0.22%. Regarding short-term risk, GMVD is more volatile compared to DXR. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check DXR's competition here
Singular Genomics Systems, Inc. (NASDAQ: OMIC)
GMVD vs OMIC Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, OMIC has a market cap of 50.8M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while OMIC trades at $20.01.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas OMIC's P/E ratio is -0.58. In terms of profitability, GMVD's ROE is +2.09%, compared to OMIC's ROE of -0.43%. Regarding short-term risk, GMVD is more volatile compared to OMIC. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check OMIC's competition here
GlucoTrack, Inc. (NASDAQ: IGAP)
GMVD vs IGAP Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, IGAP has a market cap of 50.2M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while IGAP trades at $3.24.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas IGAP's P/E ratio is -10.52. In terms of profitability, GMVD's ROE is +2.09%, compared to IGAP's ROE of -0.86%. Regarding short-term risk, GMVD is more volatile compared to IGAP. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check IGAP's competition here
Nephros, Inc. (NASDAQ: NEPH)
GMVD vs NEPH Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, NEPH has a market cap of 38.6M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while NEPH trades at $3.64.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas NEPH's P/E ratio is 50.86. In terms of profitability, GMVD's ROE is +2.09%, compared to NEPH's ROE of +0.08%. Regarding short-term risk, GMVD is more volatile compared to NEPH. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check NEPH's competition here
Milestone Scientific Inc. (AMEX: MLSS)
GMVD vs MLSS Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, MLSS has a market cap of 34.5M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while MLSS trades at $0.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas MLSS's P/E ratio is -6.50. In terms of profitability, GMVD's ROE is +2.09%, compared to MLSS's ROE of -1.66%. Regarding short-term risk, GMVD is more volatile compared to MLSS. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check MLSS's competition here
Precision Optics Corporation, Inc. (NASDAQ: POCI)
GMVD vs POCI Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, POCI has a market cap of 33.8M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while POCI trades at $4.30.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas POCI's P/E ratio is -6.07. In terms of profitability, GMVD's ROE is +2.09%, compared to POCI's ROE of -0.37%. Regarding short-term risk, GMVD is more volatile compared to POCI. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check POCI's competition here
SmileDirectClub, Inc. (NASDAQ: SDC)
GMVD vs SDC Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, SDC has a market cap of 29.1M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while SDC trades at $0.08.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas SDC's P/E ratio is -0.03. In terms of profitability, GMVD's ROE is +2.09%, compared to SDC's ROE of -1.96%. Regarding short-term risk, GMVD is less volatile compared to SDC. This indicates lower risk in terms of short-term price fluctuations for GMVD.Check SDC's competition here
Harvard Bioscience, Inc. (NASDAQ: HBIO)
GMVD vs HBIO Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, HBIO has a market cap of 27.3M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while HBIO trades at $6.00.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas HBIO's P/E ratio is -16.81. In terms of profitability, GMVD's ROE is +2.09%, compared to HBIO's ROE of -0.73%. Regarding short-term risk, GMVD is more volatile compared to HBIO. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check HBIO's competition here
Invacare Corporation (NYSE: IVC)
GMVD vs IVC Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, IVC has a market cap of 24.9M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while IVC trades at $0.66.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas IVC's P/E ratio is -0.79. In terms of profitability, GMVD's ROE is +2.09%, compared to IVC's ROE of -0.46%. Regarding short-term risk, GMVD is more volatile compared to IVC. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check IVC's competition here
Retractable Technologies, Inc. (AMEX: RVP)
GMVD vs RVP Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, RVP has a market cap of 20.4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while RVP trades at $0.68.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas RVP's P/E ratio is -2.06. In terms of profitability, GMVD's ROE is +2.09%, compared to RVP's ROE of -0.08%. Regarding short-term risk, GMVD is more volatile compared to RVP. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check RVP's competition here
Jin Medical International Ltd. (NASDAQ: ZJYL)
GMVD vs ZJYL Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ZJYL has a market cap of 16M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ZJYL trades at $2.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ZJYL's P/E ratio is 12.75. In terms of profitability, GMVD's ROE is +2.09%, compared to ZJYL's ROE of +0.04%. Regarding short-term risk, GMVD is more volatile compared to ZJYL. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ZJYL's competition here
Femasys Inc. (NASDAQ: FEMY)
GMVD vs FEMY Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, FEMY has a market cap of 11.2M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while FEMY trades at $3.71.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas FEMY's P/E ratio is -10.25. In terms of profitability, GMVD's ROE is +2.09%, compared to FEMY's ROE of -2.58%. Regarding short-term risk, GMVD is more volatile compared to FEMY. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check FEMY's competition here
Regentis Biomaterials Ltd. (AMEX: RGNT)
GMVD vs RGNT Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, RGNT has a market cap of 7.8M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while RGNT trades at $1.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas RGNT's P/E ratio is -0.08. In terms of profitability, GMVD's ROE is +2.09%, compared to RGNT's ROE of N/A. Regarding short-term risk, GMVD is more volatile compared to RGNT. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check RGNT's competition here
NanoString Technologies, Inc. (NASDAQ: NSTG)
GMVD vs NSTG Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, NSTG has a market cap of 5.1M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while NSTG trades at $0.11.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas NSTG's P/E ratio is -0.03. In terms of profitability, GMVD's ROE is +2.09%, compared to NSTG's ROE of -1.43%. Regarding short-term risk, GMVD is less volatile compared to NSTG. This indicates lower risk in terms of short-term price fluctuations for GMVD.Check NSTG's competition here
NEXGEL, Inc. (NASDAQ: NXGL)
GMVD vs NXGL Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, NXGL has a market cap of 4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while NXGL trades at $0.44.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas NXGL's P/E ratio is -1.13. In terms of profitability, GMVD's ROE is +2.09%, compared to NXGL's ROE of -0.70%. Regarding short-term risk, GMVD is more volatile compared to NXGL. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check NXGL's competition here
Predictive Oncology Inc. (NASDAQ: POAI)
GMVD vs POAI Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, POAI has a market cap of 3.6M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while POAI trades at $4.91.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas POAI's P/E ratio is -0.03. In terms of profitability, GMVD's ROE is +2.09%, compared to POAI's ROE of -107.05%. Regarding short-term risk, GMVD is more volatile compared to POAI. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check POAI's competition here
Lucyd, Inc (NASDAQ: LUCY)
GMVD vs LUCY Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, LUCY has a market cap of 2.6M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while LUCY trades at $0.65.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas LUCY's P/E ratio is -0.39. In terms of profitability, GMVD's ROE is +2.09%, compared to LUCY's ROE of -0.83%. Regarding short-term risk, GMVD is more volatile compared to LUCY. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check LUCY's competition here
Meihua International Medical Technologies Co., Ltd. (NASDAQ: MHUA)
GMVD vs MHUA Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, MHUA has a market cap of 2.4M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while MHUA trades at $7.61.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas MHUA's P/E ratio is 0.25. In terms of profitability, GMVD's ROE is +2.09%, compared to MHUA's ROE of +0.07%. Regarding short-term risk, GMVD is more volatile compared to MHUA. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check MHUA's competition here
NEXGEL, Inc. (NASDAQ: NXGLW)
GMVD vs NXGLW Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, NXGLW has a market cap of 1.8M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while NXGLW trades at $0.02.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas NXGLW's P/E ratio is -0.06. In terms of profitability, GMVD's ROE is +2.09%, compared to NXGLW's ROE of -0.70%. Regarding short-term risk, GMVD is more volatile compared to NXGLW. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check NXGLW's competition here
G Medical Innovations Holdings Ltd (NASDAQ: GMVDW)
GMVD vs GMVDW Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, GMVDW has a market cap of 1.8M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while GMVDW trades at $7.04.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas GMVDW's P/E ratio is N/A. In terms of profitability, GMVD's ROE is +2.09%, compared to GMVDW's ROE of +2.09%. Regarding short-term risk, GMVD is less volatile compared to GMVDW. This indicates lower risk in terms of short-term price fluctuations for GMVD.Check GMVDW's competition here
Avinger, Inc. (NASDAQ: AVGR)
GMVD vs AVGR Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, AVGR has a market cap of 1.5M. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while AVGR trades at $0.47.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas AVGR's P/E ratio is -0.05. In terms of profitability, GMVD's ROE is +2.09%, compared to AVGR's ROE of +17.82%. Regarding short-term risk, GMVD is less volatile compared to AVGR. This indicates lower risk in terms of short-term price fluctuations for GMVD.Check AVGR's competition here
Lucyd, Inc (NASDAQ: LUCYW)
GMVD vs LUCYW Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, LUCYW has a market cap of 296.1K. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while LUCYW trades at $0.06.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas LUCYW's P/E ratio is -0.00. In terms of profitability, GMVD's ROE is +2.09%, compared to LUCYW's ROE of -0.83%. Regarding short-term risk, GMVD is more volatile compared to LUCYW. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check LUCYW's competition here
GlucoTrack, Inc. (NASDAQ: GCTK)
GMVD vs GCTK Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, GCTK has a market cap of 165.2K. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while GCTK trades at $0.29.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas GCTK's P/E ratio is -0.01. In terms of profitability, GMVD's ROE is +2.09%, compared to GCTK's ROE of -5.82%. Regarding short-term risk, GMVD is more volatile compared to GCTK. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check GCTK's competition here
Hill-Rom Holdings, Inc. (NYSE: HRC)
GMVD vs HRC Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, HRC has a market cap of 0. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while HRC trades at $155.96.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas HRC's P/E ratio is 41.92. In terms of profitability, GMVD's ROE is +2.09%, compared to HRC's ROE of +0.14%. Regarding short-term risk, GMVD is more volatile compared to HRC. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check HRC's competition here
Analogic Corporation (NASDAQ: ALOG)
GMVD vs ALOG Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ALOG has a market cap of 0. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ALOG trades at $83.95.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ALOG's P/E ratio is 40.93. In terms of profitability, GMVD's ROE is +2.09%, compared to ALOG's ROE of -0.15%. Regarding short-term risk, GMVD is more volatile compared to ALOG. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ALOG's competition here
Antares Pharma, Inc. (NASDAQ: ATRS)
GMVD vs ATRS Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, ATRS has a market cap of 0. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while ATRS trades at $5.59.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas ATRS's P/E ratio is 14.95. In terms of profitability, GMVD's ROE is +2.09%, compared to ATRS's ROE of +0.31%. Regarding short-term risk, GMVD is more volatile compared to ATRS. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check ATRS's competition here
Apria, Inc. (NASDAQ: APR)
GMVD vs APR Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, APR has a market cap of 0. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while APR trades at $37.50.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas APR's P/E ratio is 22.59. In terms of profitability, GMVD's ROE is +2.09%, compared to APR's ROE of +9.81%. Regarding short-term risk, GMVD is more volatile compared to APR. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check APR's competition here
IntriCon Corporation (NASDAQ: IIN)
GMVD vs IIN Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, IIN has a market cap of 0. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while IIN trades at $24.23.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas IIN's P/E ratio is 226.45. In terms of profitability, GMVD's ROE is +2.09%, compared to IIN's ROE of -0.00%. Regarding short-term risk, GMVD is more volatile compared to IIN. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check IIN's competition here
Invuity, Inc. (NASDAQ: IVTY)
GMVD vs IVTY Comparison July 2026
G Medical Innovations Holdings Ltd (NASDAQ: GMVD) plays a significant role within the Healthcare sector. Its performance on the NASDAQ reflects broader market trends and attracts considerable investor interest.
Comparing market capitalization, GMVD stands at 1.8M. In comparison, IVTY has a market cap of 0. Regarding current trading prices, GMVD is priced at $0.18 on the NASDAQ, while IVTY trades at $7.39.
To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.
GMVD currently has a P/E ratio of -0.01, whereas IVTY's P/E ratio is -3.80. In terms of profitability, GMVD's ROE is +2.09%, compared to IVTY's ROE of -2.40%. Regarding short-term risk, GMVD is more volatile compared to IVTY. This indicates higher risk in terms of short-term price fluctuations for GMVD.Check IVTY's competition here